Shipo Wu
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- Viral Infections and Outbreaks Research
- Viral Infections and Vectors
- Viral gastroenteritis research and epidemiology
- Health top 10%
- Vaccine Coverage and Hesitancy
Papers in
-
- Viral Infections and Outbreaks Research 11
- SARS-CoV-2 and COVID-19 Research 10
- Viral gastroenteritis research and epidemiology 9
- Viral Infections and Vectors 5
- Epidemiology 14
- Hepatitis B Virus Studies 7
- Co-authors
- Lihua Hou (25 shared papers)Wei Chen (9 shared papers)Xiaohong Song (14 shared papers)Busen Wang (14 shared papers)Zhe Zhang (11 shared papers)Qiang Guo (4 shared papers)Jinlong Zhang (13 shared papers)Tao Zhu (5 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Viruses (2 papers)The Journal of Infectious Diseases (2 papers)Emerging Microbes & Infections (2 papers)The Lancet (2 papers)
- Partner nations
- ChinaCzechiaUnited States
In The Last Decade
Shipo Wu
37 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Infectious Diseases 699
- Health 98
- Molecular Medicine 54
- Modeling and Simulation 50
- Immunology 191
Countries citing papers authored by Shipo Wu
This map shows the geographic impact of Shipo Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shipo Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shipo Wu more than expected).
Fields of papers citing papers by Shipo Wu
This network shows the impact of papers produced by Shipo Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shipo Wu. The network helps show where Shipo Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Shipo Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial Hit paper breakdown → | 2021 | 192 |
| 2 | 2016 | 144 | |
| 3 | 2020 | 123 | |
| 4 | 2015 | 120 | |
| 5 | 2018 | 98 | |
| 6 | 2016 | 77 | |
| 7 | 2021 | 56 | |
| 8 | 2023 | 55 | |
| 9 | 2012 | 47 | |
| 10 | 2018 | 46 | |
| 11 | 2014 | 35 | |
| 12 | 2016 | 30 | |
| 13 | 2012 | 25 | |
| 14 | 2021 | 22 | |
| 15 | 2017 | 16 | |
| 16 | 2022 | 15 | |
| 17 | 2011 | 12 | |
| 18 | 2018 | 11 | |
| 19 | 2013 | 11 | |
| 20 | 2018 | 11 |
About Shipo Wu
Shipo Wu is a scholar working on Infectious Diseases, Epidemiology, Genetics, Molecular Biology and Immunology, having authored 38 papers that have together received 1.2k indexed citations. Recurring topics across this work include Virus-based gene therapy research (14 papers), Viral Infections and Outbreaks Research (11 papers), SARS-CoV-2 and COVID-19 Research (10 papers), Viral gastroenteritis research and epidemiology (9 papers), Hepatitis B Virus Studies (7 papers), Immunotherapy and Immune Responses (5 papers), Viral Infections and Vectors (5 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Infectious Diseases (699 citations), Health (98 citations), Molecular Medicine (54 citations), Modeling and Simulation (50 citations) and Immunology (191 citations). Shipo Wu has collaborated with scholars based in China, Czechia and United States. Frequent co-authors include Lihua Hou, Wei Chen, Xiaohong Song, Busen Wang, Zhe Zhang, Qiang Guo, Jinlong Zhang, Tao Zhu, Jingxin Li and Fengcai Zhu. Their work appears in journals such as Frontiers in Immunology, Viruses, The Journal of Infectious Diseases, Emerging Microbes & Infections and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.